Colucid
Colucid is focused on developing drug for the acute treatment of migraine headaches and CNS disorders.
Business Model:
Revenue: $4.1M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Colucid Information
Geographic Data
Address: 222 3rd St
City: Cambridge
State: MA
Zip: 02142
Country: US
Financial Info
Stage:
series c
Raised Last:
$37M
Raised Total:$97M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Colucid is focused on developing drug for the acute treatment of migraine headaches and CNS disorders.
Contact Phone:
+18572856495
Contact Email:
Colucid went public on 5/6/2015 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
5/6/2015
IPO Valuation:
$151M
Ticker Symbol:
CLCD
IPO Price:
$10/share
Amount Raised:
$50M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
